4.7 Article

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA

期刊

EMERGING INFECTIOUS DISEASES
卷 22, 期 7, 页码 1253-1256

出版社

CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2207.151319

关键词

-

资金

  1. Pfizer [WS79560E]
  2. Veterans Health Administration Health Services Research and Development Career Development Award [CDA 11-215]
  3. VA HSRD grant [IIR 09-099]
  4. Cubist Pharmaceuticals
  5. Cerexa, a subsidiary of Forest Laboratories

向作者/读者索取更多资源

We retrospectively analyzed data for 195 respiratory infection patients who had positive Staphyloccocus aureus cultures and who were hospitalized in 2 hospitals in Iowa and Maryland, USA, during 2003-2009. Odds for death for patients who also had influenza-positive test results were >= 4 times higher than for those who had negative influenza test results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据